{
  "_id": "3dbcf69f06cffbd7a8823aff0a0899057ac259a2893cc13a7995d92d352fbae4",
  "feed": "market-watch",
  "title": "FDA may soon approve mixing and matching COVID booster shots",
  "text": "<p>The FDA won't recommend any booster over the others but will permit people to get a booster shot that is different from the shot they first received, one of the people familiar with the matter said.</p><p>The FDA is trying to greenlight&#xa0;mixing and matching&#xa0;as soon as this week, the people familiar with the matter said. The FDA is also expected to approve&#xa0;Moderna&#xa0;Inc. MRNA&#xa0;and&#xa0;Johnson &amp; Johnson JNJ boosters this week, according to a person familiar with the matter.</p><p>The FDA has authorized extra doses of vaccines from&#xa0;Pfizer&#xa0;Inc. PFE&#xa0;and partner&#xa0;BioNTech SE BNTX&#xa0;and from Moderna for people with compromised immune systems. The FDA has also authorized Pfizer-BioNTech boosters for seniors and other people at high-risk of severe illness.</p><p>An expanded version of this report appears on WSJ.com.</p><p>Also popular on WSJ.com:</p><p>Zillow gets outplayed at its own game.</p><p>To strike a climate deal, poor nations say they need trillions from rich ones.</p>",
  "published": "2021-10-18T19:44:00.000Z",
  "tags": [
    {
      "id": "US4781601046",
      "name": "Johnson & Johnson",
      "offsets": [
        {
          "start": 373,
          "end": 390
        }
      ],
      "nexusId": "10010560"
    }
  ]
}